A study for EGFR testing in lung cancer patients.
Not Applicable
- Conditions
- Health Condition 1: null- Patients of Lung Cancer
- Registration Number
- CTRI/2015/03/005648
- Lead Sponsor
- ot yet available
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria
Patients must meet the following criteria for study entry:
•Adult male or female patients of age >= 18years.
•Diagnosed case of small cell lung cancer with availability of representative tumor specimen for genetic analysis, from the biopsy sample.
Exclusion Criteria
Exclusion Criteria
Patients who meet the following criteria will be excluded from study:
•Non-availability of biopsy sample and inadequate tissue sample.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective for this study is: <br/ ><br>Prevalence of EGFR mutations in Small Cell Lung Cancer (SCLC) patients in Indian population <br/ ><br>Timepoint: <br/ ><br>1 year
- Secondary Outcome Measures
Name Time Method The secondary objectives for this study are: <br/ ><br>Prevalence of different types of EGFR mutations in SCLC patients in Indian population <br/ ><br>Correlation of EGFR mutation status with demography <br/ ><br>Correlation of EGFR mutation status with clinico-pathological characteristics <br/ ><br>Timepoint: 1 year